Hearing aids to support cognitive functions of older adults at risk of dementia: the HearCog trial- clinical protocols
Dona MP Jayakody, Osvaldo P Almeida, Andrew H Ford, Marcus D Atlas, Nicola T Lautenschlager, Peter L Friedland, Suzanne Robinson, Marshall Makate, Lize Coetzee, Angela SP Liew, Leon Flicker
BMC Geriatrics | BMC | Published : 2020
BACKGROUND: Globally, about 50 million people were living with dementia in 2015, with this number projected to triple by 2050. With no cure or effective treatment currently insight, it is vital that factors are identified which will help prevent or delay both age-related and pathological cognitive decline and dementia. Observational data have suggested that hearing loss is a potentially modifiable risk factor for dementia, but no conclusive evidence from randomised controlled trials is currently available. METHODS: The HearCog trial is a 24-month, randomised, controlled clinical trial aimed at determining whether a hearing loss intervention can delay or arrest the cognitive decline. We will ..View full abstract
This study received funding from Ron and Peggy Bell Legacy Trust, WA Department of Health Research Translation Project Grant and Rebecca L Cooper Foundation. The Oticon A/S, Denmark, provided hearing aids for the study. None of the funding bodies has provided any intellectual input into the design of the study and will not provide any input into data collection, analysis, and interpretation of data and in writing of the manuscript.